Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating xerophthalmia

A composition and technology for dry eye, applied in the field of pharmaceutical compositions for the treatment of dry eye, can solve problems such as affecting curative effect, inability of patients to adhere to, lack and the like

Inactive Publication Date: 2011-08-10
张铭连
View PDF1 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the pace of life of modern people is fast, and the treatment of traditional Chinese medicine is limited by conditions. Many patients cannot persist, which affects its curative effect.
At present, there is a lack of compound preparations of Chinese patent medicines with relatively accurate curative effect on the treatment of this disease in China.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating xerophthalmia
  • Pharmaceutical composition for treating xerophthalmia
  • Pharmaceutical composition for treating xerophthalmia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] The pharmaceutical composition in the present embodiment is made up of following crude drug:

[0097] Habitat 10 Scrophulariaceae 30 Ophiopogon japonicus 10 Dendrobium 8 Anemarrhena 10

[0098] Trichosanthes 15 Chrysanthemum 8 Mulberry leaves 15 Gujing grass 9 Fangfeng 15.

Embodiment 2

[0100] The pharmaceutical composition in the present embodiment is made up of following crude drug:

[0101] Habitat 30 Scrophulariaceae 40 Ophiopogon japonicus 30 Dendrobium 30 Anemarrhena 20

[0102] Trichosanthes 20, chrysanthemum 30, mulberry leaves 30, Gujing grass 20, windproof 30.

Embodiment 3

[0104] The pharmaceutical composition in the present embodiment is made up of following crude drug:

[0105] Habitat 6 Scrophulariaceae 10 Ophiopogon japonicus 5 Dendrobium 5 Anemarrhena 10

[0106] Trichosanthes 10 Chrysanthemum 5 Mulberry Leaf 5 Gujing Grass 5 Fangfeng 10.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a pharmaceutical composition, in particular a pharmaceutical composition for treating xerophthalmia. The pharmaceutical composition provided by the invention is prepared from effective amounts of radix rehmanniae, figwort, ophiopogon root, dendrobium, rhizoma anemarrhenae, radix trichosanthis, chrysanthemum, mulberry leaf, pipewort, radix sileris and other raw medicines. The invention solves the problems of short action time, limited treatment, poor treatment effect and the like in the prior art. The pharmaceutical composition has the advantages of small drug toxicity, obvious treatment effect and the like.

Description

technical field [0001] The invention belongs to a pharmaceutical composition, in particular to a pharmaceutical composition for treating dry eye. Background technique [0002] Dry eye syndrome belongs to the category of "white astringent syndrome" in ophthalmology of traditional Chinese medicine. Traditional Chinese medicine believes that this disease is due to the attachment of evil heat, insufficient lung yin, accumulated heat in the spleen and stomach, deficiency of liver and kidney yin, and insufficient yin and fluid, resulting in loss of eyesight and nourishment. [0003] Current treatments for dry eye syndrome fall into three main categories: [0004] 1. Supplementary artificial tears, implantation of lacrimal plugs, and submandibular gland transplantation and other surgical treatments. At present, its western medicine treatment mainly uses topical medication to increase water retention on the corneal surface, improve corneal wetness, and stimulate tear secretion. Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61P27/02A61K36/8984
Inventor 张铭连
Owner 张铭连
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com